Panacea Biotec receives manufacturing authorization for 22 medicinal products

Mumbai: Panacea Biotec said that it has received the Certificate of GMP compliance from State Service of Ukraine on Medicines and Drugs Control with Manufacturing Authorization for 22 medicinal products, including 4 oncology products for a period valid till June 24, 2020.

Under this Manufacturing Authorization the company’s oral solid dosage manufacturing facility and oncology facility at Baddi, Himachal Pradesh has been certified as complying with the Good Manufacturing Practices, the company said in a filing to BSE.

The 22 products under approval are in various therapeutic categories including organ transplantation, diabetes management, oncology, piles management, pain management and gastroenterology etc.

Both the oral solid dosage manufacturing facility and oncology facility were inspected by the auditors from State Services of Ukraine on Medicines and Drug Control during the period from June 19, 2017, to June 24, 2017.

Panacea Biotec is a leading biotechnology company with established research, manufacturing and marketing capabilities.

It is one of the largest vaccine producers and leading Biotechnology Companies in India.